X

Electronics giant is moving into health, announcing a multi-million dollar biopharmaceutical joint venture.

The project, which has initial capital of $264.4 million is just the first part of Samsung’s planned 2.1 trillion won investment into the biomedicine and pharmaceuticals field, with the company also looking to green energy for other business opportunities. 

The Korean eletronics giant will partner with bio and pharmaceutical services provider Quintiles to manufacture treatments for cancer and arthritis and is soon to commence building of a plant in Incheon, South Korea.

Production of the medicine is expected in the first half of 2013, the company said in a statement.

The maker is also toying with a move into biosimilars. 

“Samsung is considering the establishment of another joint venture to make biosimilars this year, but nothing has been decided yet,” Kim Tae- han, Samsung’s VP, said at a briefing.

Last year the Samsung group said it would spend 23.3 trillion won in five new businesses by 2020.

3sixT GS24 EDM 728 x 90 px 02 Samsung Gets Into Drugs Business
BEL2385 4SQ Dock Banners 4SQ 728x90 Samsung Gets Into Drugs Business
TAX TIME 2024 Banner 728x90px Samsung Gets Into Drugs Business
hitachi banner 728x90 Samsung Gets Into Drugs Business
Middleton 728x90px Product Samsung Gets Into Drugs Business
Leaderboard 728x90 Samsung Gets Into Drugs Business
Flick of a switch 728x90 1 Samsung Gets Into Drugs Business
728x90 Iconic Samsung Gets Into Drugs Business
Haier 728x90 1 Samsung Gets Into Drugs Business
728x90 Samsung Gets Into Drugs Business


YOU MAY ALSO LIKE